A Phase 1b Study of LY2835219 in Combination with Multiple Single-Agent Options for Patients with Stage IV NSCLC

Type of Cancer
Lung

Site
Hackensack

Sponsor
Eli Lilly

Protocol Number
I3Y-MC-JPBJ

To Learn More Call
201-510-0910